| Pharmacological management: |
| First line uterotonic: oxytocin in step 1 |
| Second line uterotonic: sulprostone (prostaglandin E2 analogue) in step 2 |
| No misoprostol (prostaglandin E1 analogue) in each step |
| Non-pharmacological management: |
| Manual placental delivery, manual examination of the uterine cavity in step 1 |
| No intrauterine tamponade in step 1 |
| No torsion of the cervix in step 1 |
| Uterine massage in steps 1 or 2 |
| Cervical examination with speculum in steps 1 or 2 |
| No surgical treatment in steps 1 or 2 |
| No selective arterial embolization in steps 1 or 2 |
| Surgical treatment, selective arterial embolization and/or intrauterine tamponade in step 3 |
| Communication, monitoring, and investigation: |
| Alert other members of the team in steps 1 or 2 |
| Venipuncture with blood count, hemostasis in steps 1 or 2 |
| Resuscitation measure in steps 1 or 2 |
